| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3590008
Max Phase: Preclinical
Molecular Formula: C24H19N3O2
Molecular Weight: 381.44
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc(C(=O)n2c(-c3cn(C)c4ccccc34)nc3ccccc32)cc1
Standard InChI: InChI=1S/C24H19N3O2/c1-26-15-19(18-7-3-5-9-21(18)26)23-25-20-8-4-6-10-22(20)27(23)24(28)16-11-13-17(29-2)14-12-16/h3-15H,1-2H3
Standard InChI Key: IIKFDGGKZOOCSR-UHFFFAOYSA-N
Associated Targets(Human)
MCF7 126967 Activities
HepG2 196354 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
A549 127892 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Tubulin 169 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 381.44 | Molecular Weight (Monoisotopic): 381.1477 | AlogP: 4.89 | #Rotatable Bonds: 3 |
| Polar Surface Area: 49.05 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 0.92 | CX LogP: 4.62 | CX LogD: 4.62 |
| Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.45 | Np Likeness Score: -0.74 |
References
| 1. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL.. (2015) Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors., 99 [PMID:26070164] [10.1016/j.ejmech.2015.05.021] |
Source
Source(1):